Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -214.74% is 14% below its 2-year average of -188.58%, around the middle of its 2-year range (-251.90%–-134.39%).
6.37% below its 12-month average of -201.87%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -205.35%.
NET PROFIT MARGIN
-214.74%
NET PROFIT MARGIN AVG TTM
-201.87%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.37%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 697 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CapsoVision, Inc.
Market Cap
$324.05M
Net Profit Margin
-214.74%
TTM Avg
-201.87%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$318.73M
Net Profit Margin
-56.96%
TTM Avg
-82.06%
3Y Avg
-78.03%
5Y Avg
-79.87%
Market Cap
$321.75M
Net Profit Margin
-289.44%
TTM Avg
-294.02%
3Y Avg
-409.64%
5Y Avg
-336.94%
Market Cap
$309.62M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
Market Cap
$332.88M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
Market Cap
$303.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6520.67%
5Y Avg
-12425.66%
Market Cap
$331.82M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$338.34M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$297.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $324.05M | -214.74% | -201.87% | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $318.73M | -56.96% | -82.06% | -78.03% | -79.87% |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.75M | -289.44% | -294.02% | -409.64% | -336.94% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.62M | -145.12% | -145.12% | -145.12% | -145.12% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $332.88M | -81.76% | -64.66% | -75.38% | -73.80% |
| Benitec Biopharma Inc. (BNTC)vs › | $303.05M | 0.00% | 0.00% | -6520.67% | -12425.66% |
| Cabaletta Bio, Inc. (CABA)vs › | $331.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Agenus Inc. (AGEN)vs › | $338.34M | 69.34% | -109.76% | -150.31% | -135.75% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Standard BioTools Inc. (LAB)vs › | $290.97M | -103.29% | -83.69% | -107.92% | -85.90% |
Operating Margin
-188.3%
Net Profit Margin
-214.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -205.35% |
| 2026-03-31 | -251.90% |
| 2025-12-31 | -188.72% |
| 2025-09-30 | -223.88% |
| 2025-06-30 | -139.52% |
| 2025-03-31 | -193.14% |
| 2024-12-31 | -134.39% |
| 2024-09-30 | -195.35% |
| 2024-06-30 | -185.23% |
| 2024-03-31 | -168.34% |
